biologicals

biologicals

美 [?ba???lɑd??k(?)l] 　英 [?ba???l?d??k(?)l]

• adj.生物學(上)的
• n.【藥】生物制品
• 網絡生物制劑；生物材料；生物制劑生物制品

詞形變化

同義詞

英漢解釋

英英解釋

例句

Anti-infectious agents like quinolones, macrolides, TCM with anti-infectious effect and biologicals & biochemicals, vitamins had grown.

喹諾酮類、大環內酯類、抗感染中成藥類抗感染藥物以及生物制品與生化藥物、維生素類藥物均有增長；

Members are appointed by the Director of the WHO Department of Immunization, Vaccines and Biologicals (IVB).

委員由世衛組織免疫、疫苗和生物制品司（IVB）司長委任。

By controlling the relative humidity level in a home, the growth of some sources of biologicals can be minimized.

通過控制房間相對濕度，一些生物污染源的增長就相對降低。

biologicals methods: outputting the nitrogen and phosphorus with biological mass and controlling the algae with biological means.

生物方法：用生物量輸出氮磷與用生物方法對小型浮游藻類進行控制。

In severe disease with insufficient treatment response, the new biologicals are indicated before marked joint damages occur.

在治療反應不足的嚴重的疾病，新的生物制劑有顯著的聯合損失表示之前發生。

It has provided useful data for clintcle using biologicals to treat some diseases and lack in. . .

這為臨床合理使用生物制劑治療某些疾病及微量元素缺乏癥提供了有用數據。

Adopting the routine allergy tests for detecting the allergy of biologicals.

采用生物制品過敏試驗常規檢測方法。

"I am thrilled, " says Joe Cohen, who leads the malaria vaccine project at GSK Biologicals.

“我很激動，”葛蘭素史克生物技術公司主持了這個瘧疾疫苗項目的喬·科恩說。

Chen X Y. 1982. Preparation of fatal bovine serum in tissue culture[J]. International Journal of Biologicals, (1): 37.

陳秀英。1982。用于組織培養的胎牛血清的制備[J]。國際生物制品學雜志，（1）：37。

Another trend is that there are more regional deals being done, and more deals done on biologicals.

另一個趨勢是區域性和生物相關性的交易在增多。

serums, vaccines and hormone products may now be referred to as biologicals

血清、疫苗和內泌素制品，現在可稱為生物制劑

Ensure proper preparation, packaging, distribution and storage of vaccines, serums, biologicals and other drugs and pharmaceuticals

確保適當的準備，包裝，分發和儲存疫苗，血清，生物制劑及其他藥物和藥品

Current status and future directions in our Chinese animal biologicals

我國動物生物制品的研究狀況及發展方向

Analyses pros and cons of management mode of our country preventative biologicals supply step by step at present

目前我國預防性生物制品逐級供應管理模式的利弊分析